Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Ecolab Inc. (ECL) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ecolab Inc. (ECL) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for February 16th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 16:
Ecolab Inc. (ECL - Free Report) : This hygiene solutions company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5% over the last 60 days.
Ecolab Inc. Price and Consensus
Ecolab Inc. price-consensus-chart | Ecolab Inc. Quote
Ecolab's shares gained 17.4% over the last three months compared with the S&P 500’s advance of 10.4%. The company possesses a Momentum Score of A.
Ecolab Inc. Price
Ecolab Inc. price | Ecolab Inc. Quote
Cadence Design Systems, Inc. (CDNS - Free Report) : This semiconductor company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.
Cadence Design Systems, Inc. Price and Consensus
Cadence Design Systems, Inc. price-consensus-chart | Cadence Design Systems, Inc. Quote
Cadence Design Systems' shares gained 34.2% over the last six months compared with the S&P 500’s advance of 13.9%. The company possesses a Momentum Score of B.
Cadence Design Systems, Inc. Price
Cadence Design Systems, Inc. price | Cadence Design Systems, Inc. Quote
Korro Bio, Inc. (KRRO - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.4% over the last 60 days.
Korro Bio, Inc. Price and Consensus
Korro Bio, Inc. price-consensus-chart | Korro Bio, Inc. Quote
Korro Bio's shares gained 38.3% over the last three months compared with the S&P 500’s advance of 10.4%. The company possesses a Momentum Score of A.
Korro Bio, Inc. Price
Korro Bio, Inc. price | Korro Bio, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.